ICU Medical, Inc. (ICUI) News
Filter ICUI News Items
ICUI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ICUI News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ICUI News From Around the Web
Below are the latest news stories about ICU MEDICAL INC that investors may wish to consider to help them evaluate ICUI as an investment opportunity.
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceSAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical’s presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings |
Calculating The Fair Value Of ICU Medical, Inc. (NASDAQ:ICUI)Key Insights The projected fair value for ICU Medical is US$172 based on 2 Stage Free Cash Flow to Equity With US$157... |
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price TargetsShareholders might have noticed that ICU Medical, Inc. ( NASDAQ:ICUI ) filed its third-quarter result this time last... |
ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsICU Medical ( NASDAQ:ICUI ) Third Quarter 2024 Results Key Financial Results Revenue: US$589.1m (up 6.5% from 3Q 2023... |
ICU Medical Inc (ICUI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...ICU Medical Inc (ICUI) reports robust financial performance with a 7% revenue increase and raises full-year guidance, while unveiling a strategic partnership with Otsuka Pharmaceutical. |
ICU Medical (ICUI) Tops Q3 Earnings and Revenue EstimatesICU Medical (ICUI) delivered earnings and revenue surprises of 27.20% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
ICU Medical: Q3 Earnings SnapshotICUI) on Tuesday reported a loss of $33 million in its third quarter. The San Clemente, California-based company said it had a loss of $1.35 per share. Earnings, adjusted for amortization costs and pretax expenses, came to $1.59 per share. |
ICU Medical Announces Third Quarter 2024 Results and Updates Its Fiscal Year 2024 GuidanceSAN CLEMENTE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2024. Third Quarter 2024 Results Third quarter 2024 revenue was $589.1 million, as compared to $553.3 million in the same period in the prior year. GAAP gross profit for the third quarter of 2024 was $204.9 million, as compared to $183.9 million in t |
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North AmericaICU Medical, Inc. (NASDAQ:ICUI), a worldwide leader in the development, manufacture and sale of innovative medical devices, and Otsuka Pharmaceutical Factory, Inc. (OPF), global IV solutions manufacturing subsidiary of Otsuka Holdings Co., Ltd., together announce the creation of a joint venture to provide additional supply chain resiliency and innovation to the North American IV solutions market. |
ICU Medical to Participate at the UBS Global Healthcare ConferenceSAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical’s presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on We |